ZS Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
ZS Pharma, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $144.30 million as of 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2015-11-09
- 2015-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $144.30M.
- 2015-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $105.90M.
- 2015-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $77.20M.
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $65.90M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2015-09-30 | $144.30M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $105.90M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $77.20M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $65.90M 10-K · filed 2015-03-13 |
| 2014-09-30 | $58.00M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $28.50M 10-Q · filed 2014-08-14 |